Last reviewed · How we verify
NCT05132283
Urologic Lymphadenectomy in AMIGO
NA trial testing 3D Slicer in Urologic Cancer in 20 participants. Status unknown.
26 August 2025
Quick facts
| Lead sponsor | Dana-Farber Cancer Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 1 April 2022 |
| Primary completion | 26 August 2025 |
| Estimated completion | 26 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 3D Slicer
- Monaco
Conditions studied
- Urologic Cancer — all drugs for Urologic Cancer →
- Lymph Node Metastasis — all drugs for Lymph Node Metastasis →
Sponsor
Dana-Farber Cancer Institute
Who can join
18 and older, any sex, with Urologic Cancer or Lymph Node Metastasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study involves the use of two navigation systems, the 3D Slicer-based navigation system, and the Siemens Monaco systems, to simplify the complexity of image-guided lymphadenectomy procedures (surgery to remove one or more lymph nodes) in patients with urological cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05132283
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urologic Cancer
Currently open trials in the same condition.
- NCT06397287 — PROM Project Urology · recruiting
- NCT07416630 — Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients · NA · recruiting
- NCT05899361 — A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest · NA · recruiting
- NCT05725304 — The Registry of Genetic Expression of Taiwan Urologic Cancer · active not recruiting
- NCT06357416 — The Man Van Project · NA · recruiting
Other Dana-Farber Cancer Institute trials
Trials by the same sponsor.
- NCT07519200 — Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention · NA · not yet recruiting
- NCT07499999 — Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk fo · Phase 2 · not yet recruiting
- NCT05825469 — Development and Testing of Nutritional Algorithms (NACHO) · NA · not yet recruiting
- NCT07516353 — my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults · NA · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05132283 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dana-Farber Cancer Institute
- Last refreshed: 24 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05132283.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing